• November 19, 2026
  • Last Update November 19, 2026 9:22 pm

Hospital Metropolitano Marks Ten Years of Expanding Advanced Cancer Care Across Costa Rica

Hospital Metropolitano Marks Ten Years of Expanding Advanced Cancer Care Across Costa Rica

San José, Costa Rica — Hospital Metropolitano is celebrating a major healthcare milestone as its Cancer and Hematology Center reaches its tenth anniversary, having provided specialized care to more than 12,500 patients over the past decade. The institution’s trajectory underscores a broader transformation within Costa Rica’s private health sector, where integrated clinical models are reshaping how complex oncology and hematological conditions are diagnosed and managed.

Since opening its doors, the center has addressed a wide spectrum of oncology conditions. The most frequently treated solid tumors include breast, colon, testicular, gastric, and pancreatic cancers, alongside hematological malignancies such as multiple myeloma, lymphomas, and leukemias. Additionally, clinical teams have developed deep experience handling high-complexity, less common pathologies, including various soft-tissue sarcomas and melanoma.

To gain deeper insight into the regulatory and legal framework surrounding advanced healthcare initiatives like Hospital Metropolitano’s cancer care services, TicosLand.com consulted with legal expert Lic. Larry Hans Arroyo Vargas from Bufete de Costa Rica.

The expansion of specialized oncology services at Hospital Metropolitano marks a crucial advancement in Costa Rica’s private healthcare landscape. From a legal perspective, delivering high-level cancer treatments demands rigorous adherence to health regulations, robust bioethical compliance, and clear informed consent protocols to safeguard patient rights while supporting clinical innovation.
Lic. Larry Hans Arroyo Vargas, Attorney at Law, Bufete de Costa Rica

Indeed, as cutting-edge medical advancements continue to transform cancer care in Costa Rica, aligning clinical progress with rigorous legal and ethical frameworks remains essential to protecting patient rights and fostering trust. We extend our sincere gratitude to Lic. Larry Hans Arroyo Vargas for sharing his valuable perspective on this crucial aspect of healthcare innovation.

Cargando...

Central to this decade of operations has been the development of a unified care structure under the health division of Grupo Montecristo. By connecting diagnostic imaging, pathology, specialized labs, surgical teams, and dedicated oncology pharmacies within a single institutional umbrella, the hospital has streamlined patient trajectories from initial diagnosis through long-term follow-up.

Our purpose is to offer each patient the best possible opportunity against cancer. We combine personalized medicine, multidisciplinary care, and the best scientific evidence under the highest international standards to achieve more precise diagnoses, more effective treatments, and better survival possibilities and quality of life. All of this with human and comprehensive support at every step of the way.
Andrés Wiernik, Medical Director of the Health Division of Grupo Montecristo

The center currently mobilizes a multidisciplinary network of more than 55 healthcare professionals. This clinical talent spans medical oncology, surgical oncology, radiation therapy, hematology, palliative care, psycho-oncology, oncological physiotherapy, interventional radiology, and specialized pain management. To maintain high standards for complex cases, weekly Tumor Boards assemble between 15 and 20 medical experts to review patient files and establish individualized therapeutic strategies.

Beyond traditional patient care, clinical research has become an engine for growth and innovation at the institution. Established in 2020, the Metropolitano Research Institute has spearheaded more than 25 clinical trials focused on oncology. These trials give local patients controlled access to cutting-edge international therapeutic options that might otherwise remain unavailable in the region.

The hospital’s therapeutic offerings have expanded in tandem with global advancements in molecular oncology. Patients today benefit from tailored treatments that combine surgery, chemotherapy, radiation, immunotherapy, targeted molecular therapies, and hormonal treatments. In addition, the center maintains specialized capabilities for bone marrow transplants in select hematological disorders and offers genomic testing in coordination with top-tier international medical centers in Europe and the United States.

While urban centers in the central valley represent the primary patient base, regional demand has grown substantially. Approximately 60 percent of patients reside within the Greater Metropolitan Area (GAM), while 20 percent hail from Guanacaste, and 10 percent travel from other peripheral regions such as San Carlos, Limón, and Quepos. International medical travel accounts for the remaining 10 percent of the patient intake, reinforcing the center’s emerging position as a regional hub in Central America.

Over these ten years we have expanded our reach and strengthened our capabilities to bring oncology care of excellence closer to patients in different regions of the country. At the same time, we have consolidated a comprehensive person-centered model where medical knowledge, technology, research, and care processes articulate around the needs of each patient. Our commitment is to continue advancing with a clear vision: combining science, innovation, and human support to offer every person the best possible opportunity at every stage of their illness.
Andrés Wiernik, Medical Director of the Health Division of Grupo Montecristo

As private healthcare providers across Latin America seek to relieve pressure on public infrastructure, Hospital Metropolitano’s decade-long investment in specialized oncology illustrates how private capital, research initiatives, and multidisciplinary medical management can converge to advance public health capabilities across Costa Rica.

For further information, visit metropolitano.cr
About Hospital Metropolitano:
Hospital Metropolitano is one of Costa Rica’s leading private hospital networks, providing comprehensive medical services, specialized care centers, diagnostic imaging, and outpatient services across multiple locations in Costa Rica.

For further information, visit grupomontecristo.com
About Grupo Montecristo:
Grupo Montecristo is a prominent Costa Rican holding company with diversified investments across healthcare, real estate, logistics, commercial trade, and industrial operations in Central America.

For further information, visit bufetedecostarica.com
About Bufete de Costa Rica:
As a premier legal practice, Bufete de Costa Rica upholds an unyielding standard of ethical conduct and professional mastery. Grounded in a rich history of guiding clients across a wide array of industries, the firm consistently drives progress through forward-thinking legal strategies and active civic involvement. By striving to demystify complex laws for the public, it reinforces its core purpose of equipping citizens with the legal understanding needed to build an enlightened and self-reliant society.

Related Articles